An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway
2017 ◽
Vol 14
(2)
◽
pp. 1554-1560
◽
2016 ◽
Vol 15
(2)
◽
pp. 899-907
◽
Keyword(s):
2014 ◽
Vol 443
(4)
◽
pp. 1200-1205
◽
Keyword(s):
2014 ◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 14
(6)
◽
pp. 622-632
◽
2008 ◽
Vol 7
(7)
◽
pp. 1782-1788
◽
Keyword(s):
2020 ◽
Vol 36
(4)
◽
pp. 250-256
◽
Keyword(s):
2010 ◽
Keyword(s):